BCGは、グローバルヘルス機関と協働して、性別、人種、教育、社会的地位や経済状態、地域に関係なく、すべての人々が健康で生産的な生活を送る上で平等な機会を得られるようにすることに取り組んでいます。
Whether combatting the HIV epidemic in South Africa, advancing health equity in India, or facilitating the development of life-saving medicines for low- and middle-income countries, BCG works to bring innovative solutions to the people who need it most.
We partner with governments, international health organizations, foundations, and healthcare companies to drive and enable equitable and high-quality health for all.
Achieving health equity is no longer just a human rights issue, it’s become a business imperative too. Both public and private sector organizations today face growing pressure from investors, civil society, healthcare providers, and patients to address health equity; those that do can leverage the opportunity to unlock commercial advantage and value. At BCG, we are focused on driving health equity around the globe. We have teams working on the ground all over the world to reduce disease, improve global health, and save lives.
Our global health consulting team helps clients build capabilities in many areas, including the following:
We believe that, to improve health equity and speed progress toward the UN’s health-related Sustainable Development Goals, the global health community needs an approach built on collaboration and innovation. For decades, we have forged enduring relationships with leading global health organizations, including the Bill & Melinda Gates Foundation, Gavi, the Global Fund, the World Bank Group, the World Health Organization, Welcome Trust, and Unitaid, in addition to governments around the world. BCG often serves as a link that connects multiple, disparate efforts to build a powerful response to global health issues.
The mRNA Technology Transfer Programme developed by MPP and supported by BCG aims to improve global health fairness in developing countries.
With the support of Africa’s Home-Grown Solutions Accelerator, African entrepreneurs are delivering world-class, home-grown health care solutions.
Tackling Antimalarial Drug Resistance in Africa
BCG supported the World Health Organization in developing a strategy to address antimalarial drug resistance in Africa. The team drew on expertise from more than 70 interviews and reviewed over 100 publications to identify interventions that delay the spread of resistant parasites. BCG then worked with the Global Fund, which invests billions each year to fight malaria, to define pathways to implementation and ensure that future treatments remain effective.
Improving Children's Health
Together with the Bill & Melinda Gates Foundation, our global health consultants developed a real-time risk score tool that analyzes patient care, predicts risk, and enables targeted intervention, thus helping to maximize scarce resources and improve health outcomes for children.
Supporting HIV Service Delivery
We partnered with the United States Agency for International Development (USAID) to develop a user-centric approach for harnessing advanced analytics in the fight against HIV. This work is an important step toward reaching the goal of achieving an AIDS-free generation.
Accelerating the Development of COVID Testing, Treatment, and Vaccines
BCG worked with WHO, UNICEF, Unitaid, the Global Fund, BMGF, GAVI, the World Bank, and other organizations and partners to support the Access to COVID-19 Tools (ACT) Accelerator, a groundbreaking partnership that has accelerated the development, production, and equitable distribution of COVID-19 tests, treatments, and vaccines.
Sanofi’s Sandrine Bouttier-Stref on how climate change will disproportionately impact vulnerable populations and the role of business in developing comprehensive solutions.
Too often is it taken for granted that the environment is a massive determinant of human well-being. Putting health at the center of our climate discussions is critical.
BCG's Emily Serazin sat down with Seth Berkley CEO of Gavi, to discuss how we can guarantee fair and equitable access to vaccines for every country in the world.
In the wake of a full-scale transformation, the International Vaccine Institute expands its global footprint and advances health equity for the poorest countries in the world.
Our global health consulting and industry experts partner with leading international health organizations, corporations, nonprofits, and philanthropic organizations to both arrive at solutions for global health issues and threats and improve overall access to care.
